ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

FOREIGN POLICY-Less than Strategie

on the basis of reduction of the ceiling prices of bulk drugs, the National Pharmaceutical Pricing Authority (NPPA) in its first significant action has certainly scored brownie points; but just how much of an impact will this have on the overall and sharply rising public/private expenditure on medicines and therefore on health care?

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top